Stocks and Investing Stocks and Investing
Mon, April 25, 2022
Sun, April 24, 2022
Fri, April 22, 2022
Thu, April 21, 2022

Shagun Singh Maintained (ABT) at Buy with Decreased Target to $143 on, Apr 21st, 2022


Published on 2024-10-27 20:33:20 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $146 to $143 on, Apr 21st, 2022.

Shagun has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 0 agree with Shagun's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Shagun


  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
  • Travis Steed of "B of A Securities" Initiated at Strong Buy and Held Target at $140 on, Wednesday, March 2nd, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022